Comparison of De Novo IgM and IgG Anti-Hla DSA Between Belatacept and Calcineurin Treated Patients: An Analysis of the BENEFIT and BENEFIT-EXT Trial Cohorts

American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.14939
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Frequency of Anti-Toxoplasma IgM and IgG Antibodies in Leukemic Patients

Alborz University Medical Journal
2015English

Prostatectomy: A Comparison of Cost-Benefit Analysis Between Open Surgery and Robotic Techniques

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Benefit-Cost Analysis and the Environment

Science
MultidisciplinaryPhilosophy of ScienceHistory
1996English

Patients, Doctors, and Sickness Benefit

BMJ
2003English

National Prevalence Estimates for Cytomegalovirus IgM and IgG Avidity and Association Between High IgM Antibody Titer and Low IgG Avidity

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2011English

Role of Anti-Ea-(D) IgM and Anti-Ea-(D) IgG Tests in Patients With Primary EBV Infection, Lymphomas and Immunosuppression

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2018English

Cost and Benefit Analysis of Contract Farming

Shanlax International Journal of Economics
2019English

Benefit of Low-Dose Aspirin and Non-Steroidal Anti-Inflammatory Drugs in Septic Patients

Critical Care
Critical CareIntensive Care Medicine
2012English

Aqueous Nitrate Waste Treatment: Technology Comparison, Cost/Benefit, and Market Analysis

1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy